Study | Diagnosis target | Reference method | Number of subjects (control/patient) | Blood pressure measurement method | Sensitivity | Specificity |
---|---|---|---|---|---|---|
Vega et al. [111] | PAD | Angiography | 158a (27/131) | ABI | 95%–97% | 56%–89% |
Wikström et al. [56] | PAD | Angiography | 533a (421/112) | ABI | 15%–20% | 99% |
Parameswaran et al. [115] | PAD | Doppler waveform analysis | 114a (79/35) type 2 diabetes | ABI | 63% | 97% |
Lijmer et al. [117] | PAD | Angiography | 106a (0/106) | ABI | 79% | 96% |
Schröder et al. [112] | PAD | Duplex Ultrasound | 216 (103/113) | ABI | 68% | 99% |
Niazi et al. [113] | PAD | Angiography | 208a (42/166) | ABI | 68% | 83% |
Guo et al. [114] | PAD | Angiography | 298 (277/21) | ABI | 91% | 86% |
Premalatha et al. [116] | PAD | Duplex ultrasound | 94 (26/68) type 2 diabetes | ABI | 70.6% | 88.5% |
Williams et al. [118] | PAD | Duplex ultrasound | 41a (27/14) | ABI | 83% | 100% |
Williams et al. [118] | PAD | Duplex ultrasound | 32a (25/7) Diabetes | ABI | 100% | 88% |
Williams et al. [118] | PAD | Duplex ultrasound | 57a (41/16) Diabetes with neuropathy | ABI | 53% | 95% |
Williams et al. [118] | PAD | Duplex ultrasound | 41a (27/14) | TBI | 100% | 81% |
Williams et al. [118] | PAD | Duplex ultrasound | 32a (25/7) Diabetes | TBI | 91% | 65% |
Williams et al. [118] | PAD | Duplex ultrasound | 57a (41/16) Diabetes with neuropathy | TBI | 100% | 61% |
Park et al. [152] | PAD | Angiography | 30a (17/13) (Diabetes gangrene) | TBI | 100% | 100% |